Mind-NRG (www.mind-nrg.com), a Switzerland-based company focused on the development of a peptidic neurotrophic factor (NRG-101) with disease modifying potential that crosses the blood-brain barrier by a receptor-mediated transport to reach its target.
Funding Rounds (3) - $23.52MUpdate
|Sep 4, 2013||Bio Portfolio - Mind-NRG Successfully Completes 6 Million Euro (~8 Million USD) Series B Financing.|
|Jan 12, 2011||OnBioVC - Mind-NRG raises 2000000 in venture round|
|Oct 27, 2010||FinSMEs - FinSMEs|
Rue de Jargonnant 2